Literature DB >> 27502125

Advances in neuroimaging in frontotemporal dementia.

Elizabeth Gordon1, Jonathan D Rohrer1, Nick C Fox1.   

Abstract

Frontotemporal dementia (FTD) is a clinically and neuroanatomically heterogeneous neurodegenerative disorder with multiple underlying genetic and pathological causes. Whilst initial neuroimaging studies highlighted the presence of frontal and temporal lobe atrophy or hypometabolism as the unifying feature in patients with FTD, more detailed studies have revealed diverse patterns across individuals, with variable frontal or temporal predominance, differing degrees of asymmetry, and the involvement of other cortical areas including the insula and cingulate, as well as subcortical structures such as the basal ganglia and thalamus. Recent advances in novel imaging modalities including diffusion tensor imaging, resting-state functional magnetic resonance imaging and molecular positron emission tomography imaging allow the possibility of investigating alterations in structural and functional connectivity and the visualisation of pathological protein deposition. This review will cover the major imaging modalities currently used in research and clinical practice, focusing on the key insights they have provided into FTD, including the onset and evolution of pathological changes and also importantly their utility as biomarkers for disease detection and staging, differential diagnosis and measurement of disease progression. Validating neuroimaging biomarkers that are able to accomplish these tasks will be crucial for the ultimate goal of powering upcoming clinical trials by correctly stratifying patient enrolment and providing sensitive markers for evaluating the effects and efficacy of disease-modifying therapies. This review describes the key insights provided by research into the major neuroimaging modalities currently used in research and clinical practice, including what they tell us about the onset and evolution of FTD and how they may be used as biomarkers for disease detection and staging, differential diagnosis and measurement of disease progression. This article is part of the Frontotemporal Dementia special issue.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  frontotemporal dementia; neuroimaging

Mesh:

Year:  2016        PMID: 27502125     DOI: 10.1111/jnc.13656

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

Review 1.  Language impairment in primary progressive aphasia and other neurodegenerative diseases.

Authors:  D R Rahul; R Joseph Ponniah
Journal:  J Genet       Date:  2019-11       Impact factor: 1.166

2.  Regional structural hypo- and hyperconnectivity of frontal-striatal and frontal-thalamic pathways in behavioral variant frontotemporal dementia.

Authors:  David Jakabek; Brian D Power; Matthew D Macfarlane; Mark Walterfang; Dennis Velakoulis; Danielle van Westen; Jimmy Lätt; Markus Nilsson; Jeffrey C L Looi; Alexander F Santillo
Journal:  Hum Brain Mapp       Date:  2018-06-20       Impact factor: 5.038

3.  Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging.

Authors:  Kunal P Patel; David T Wymer; Vinay K Bhatia; Ranjan Duara; Chetan D Rajadhyaksha
Journal:  Radiographics       Date:  2020 Jan-Feb       Impact factor: 5.333

4.  The Role of Oxytocin in Social Circuits and Social Behavior in Dementia.

Authors:  Olivier Piguet; Rebekah M Ahmed; Fiona Kumfor
Journal:  Methods Mol Biol       Date:  2022

5.  Radiomics Model for Frontotemporal Dementia Diagnosis Using T1-Weighted MRI.

Authors:  Benedetta Tafuri; Marco Filardi; Daniele Urso; Roberto De Blasi; Giovanni Rizzo; Salvatore Nigro; Giancarlo Logroscino
Journal:  Front Neurosci       Date:  2022-06-20       Impact factor: 5.152

Review 6.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

Review 7.  Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility.

Authors:  Sheena I Dev; Bradford C Dickerson; Alexandra Touroutoglou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.

Authors:  Neetu Soni; Manish Ora; Girish Bathla; Chandana Nagaraj; Laura L Boles Ponto; Michael M Graham; Jitender Saini; Yusuf Menda
Journal:  Neuroradiol J       Date:  2021-03-05

Review 9.  Imaging and fluid biomarkers in frontotemporal dementia.

Authors:  Lieke H Meeter; Laura Donker Kaat; Jonathan D Rohrer; John C van Swieten
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

10.  Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries.

Authors:  Claudia Duran-Aniotz; Paulina Orellana; Tomas Leon Rodriguez; Fernando Henriquez; Victoria Cabello; María F Aguirre-Pinto; Tamara Escobedo; Leonel T Takada; Stefanie D Pina-Escudero; Oscar Lopez; Jennifer S Yokoyama; Agustin Ibanez; Mario A Parra; Andrea Slachevsky
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.